STOCK TITAN

Nagarro partners with BioT to deliver best-in-class software for medical devices

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Rhea-AI Summary

Nagarro has announced a strategic partnership with BioT Medical, aimed at enhancing medical device connectivity. This collaboration allows device manufacturers to swiftly transform their products into connected care platforms, enabling personalized patient care systems integrated with existing workflows. According to Daniel Adler, CEO of BioT Medical, this partnership will foster innovation and growth for both companies, delivering enhanced value for medical device manufacturers and patients. Nagarro's expertise in digital health solutions will complement BioT's no-code platform for a more streamlined healthcare ecosystem.

Positive
  • Partnership with BioT Medical enhances capabilities in connected medical devices.
  • Allows device manufacturers to create connected care platforms quickly.
  • Improves patient care through integration with existing workflows.
Negative
  • None.

DUBAI, UAE, Nov. 24, 2021 /PRNewswire/ -- Nagarro, a global digital engineering company, and BioT Medical, a No-code connected-care platform for medical devices, announced a strategic partnership. In an age of data-driven hyper-personalized care, maximizing the medical device potential has never been more critical. The Nagarro BioT partnership represents the best of two worlds, digital engineering excellence, and connected medical device mastery.

This partnership will allow device manufacturers to transform any medical device into a connected care platform within days and build an end-to-end personalized patient care system that is purposefully built for their needs and is fully integrated with the existing caregiver's ecosystem and workflows. Device manufacturers can now benefit from a direct-to-consumer relationship while providing caregivers with better care capabilities using their existing workflows. 

"Our partnership with Nagarro will help fuel both companies' continued innovation and growth efforts. Through our regulated connected care, no-code platform, BioT will enable Nagarro to easily and quickly expand their best-in-class digital health offerings to the broader healthcare market. Together we can deliver a new level of value for medical device manufacturers, their patients, and the entire healthcare ecosystem," says Daniel Adler, Co-Founder & CEO at BioT Medical

"Digital health ecosystems evolve every day, so do connected medical devices and Software as a Medical Device. The future will be for those who understand the value of connected data integrated into their SaaS solutions and creating personalized care experiences. We are very excited by what BioT is doing in the Life Sciences space. Together we represent that vision. We have a long history of developing Life Sciences solutions around the world and look forward to bringing even more complete and integrated solutions with this exciting partnership," added Andrei Doibani, Global Business Unit Head for Life Sciences and Healthcare at Nagarro. 

About BioT 

BioT is a medical-grade PaaS (Platform-as-a-service) that, for the first time, introduces a no-code approach to the regulated medical device space. It's a game-changing solution to get medical devices on the cloud in a snap using a template-based drag-and-drop approach, without losing precious time or investing huge development efforts and costs. BioT's Triple-C Connect-Collaborate-Care solution enables medical device manufacturers to securely connect devices to a medical-grade cloud, boost personalized engagement and improve health outcomes through collaboration between patients and caregivers, and turn data into actionable insights to improve clinical decision-making and care experiences. For more information, visit www.biot-med.com.  

About Nagarro 

Nagarro, a global digital engineering leader, helps clients become innovative, digital-first companies and thus, win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its approach of "Thinking Breakthroughs". Nagarro employs over 10,000 people in 26 countries. For more information, visit www.nagarro.com.  

FRA: NA9 (SDAX, ISIN DE000A3H2200, WKN A3H220) 

For inquiries, please contact press@nagarro.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nagarro-partners-with-biot-to-deliver-best-in-class-software-for-medical-devices-301431469.html

SOURCE Nagarro

FAQ

What is the significance of the Nagarro and BioT Medical partnership?

The partnership enhances medical device connectivity and allows manufacturers to quickly transform devices into connected care platforms.

How will the partnership benefit medical device manufacturers?

It enables manufacturers to develop personalized patient care systems integrated with caregiver workflows, improving care capabilities.

What are the main features of BioT Medical's platform?

BioT offers a no-code approach for connecting medical devices to cloud platforms, enhancing patient engagement and clinical decision-making.

When was the Nagarro and BioT Medical partnership announced?

The partnership was announced on November 24, 2021.

What is Nagarro's focus in the healthcare sector?

Nagarro focuses on digital engineering solutions to help healthcare companies innovate and adapt to evolving digital health ecosystems.

NAGARRO SE

OTC:NGRRF

NGRRF Rankings

NGRRF Latest News

NGRRF Stock Data

1.13B
8.00M
48.1%
28.9%
Information Technology Services
Technology
Link
United States of America
Munich